SEC Form 4 · accession 0001209191-15-082232
LEMAITRE VASCULAR INC · LMAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter R Gebauer
Officer — President, International OP
Period of report
Nov 23, 2015
Accepted (ET)
Nov 25, 2015 · 4:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001158895
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 23, 2015 | M | 11,971 | $0.102 | A | 82,391 | D | |
| Common StockF2 | Nov 23, 2015 | S | 11,971 | $15.3102 | D | 70,420 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3,F4 | $0.102 | Nov 23, 2015 | M | 11,971 | D | Jun 2, 1997 | Jun 2, 2007 | Common Stock | 11,971 | 50,000 | D |
Explanation of responses
- F1Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
- F2The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $15.05 to $15.80. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
- F3This option is fully vested and exercisable.
- F4This stock option was originally reported on Form 3 as having an expiration date of June 2, 2007, but does not in fact have an expiration date. Because an expiration date is required to be reported, the originally reported expiration date is included for the sake of consistency.